15th Mar 2019 12:00 pm |
RNS |
Change of TIDM |
4th Mar 2019 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
11th Feb 2019 7:00 am |
RNS |
Verseon presents low bleed PROACs at ISC 2019 |
4th Feb 2019 7:00 am |
RNS |
First participant dosed in Verseon clinical trial |
29th Jan 2019 7:00 am |
RNS |
Directorate Change |
8th Jan 2019 12:00 pm |
RNS |
Additional listing confirmation |
3rd Jan 2019 10:20 am |
RNS |
Additional Listing & Total Voting Rights |
27th Dec 2018 7:00 am |
RNS |
Additional Listing and Total Voting Rights |
6th Nov 2018 7:00 am |
RNS |
Result of AGM and changes to the Board |
5th Nov 2018 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
24th Oct 2018 7:00 am |
RNS |
Announcement of 2018 Annual General Meeting |
11th Oct 2018 7:00 am |
RNS |
Blockchain agreement with Neuseren |
1st Oct 2018 8:59 am |
RNS |
Additional Listing & Total Voting Rights |
18th Sep 2018 7:00 am |
RNS |
Verseon unveils new blockchain technology |
13th Sep 2018 7:00 am |
RNS |
Verseon commences anticoagulant phase I trial |
31st Aug 2018 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
16th Aug 2018 7:00 am |
RNS |
Change of Adviser |
8th Aug 2018 7:00 am |
RNS |
Interim Results |
18th Jul 2018 7:00 am |
RNS |
Verseon submits phase I protocol for VE-1902 |
6th Jul 2018 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
2nd Jul 2018 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
25th Jun 2018 7:00 am |
RNS |
Final Results |
14th Jun 2018 7:00 am |
RNS |
Verseon preparing for anticoagulant phase I trial |
13th Jun 2018 7:03 am |
RNS |
Verseon closes US$ 22.7M mortgage |
12th Jun 2018 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
7th Jun 2018 7:00 am |
RNS |
Verseon presents anticoagulants at BIO 2018 |
2nd May 2018 7:00 am |
RNS |
Verseon presents DME efficacy data at ARVO 2018 |
18th Apr 2018 7:00 am |
RNS |
Verseon presents anticancer agents at AACR 2018 |
3rd Apr 2018 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
5th Mar 2018 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
10th Jan 2018 7:00 am |
RNS |
Verseon presents HAE program at Biotech Showcase |
2nd Jan 2018 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
15th Nov 2017 7:00 am |
RNS |
Verseon presents second anticoagulant candidate |
14th Nov 2017 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
8th Nov 2017 7:00 am |
RNS |
Verseon presents anticancer agents at BIO-Europe |
8th Nov 2017 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
20th Oct 2017 7:00 am |
RNS |
Result of Special Meeting & Board Appointment |
2nd Oct 2017 7:00 am |
RNS |
Verseon presents new DME efficacy results |
25th Sep 2017 7:00 am |
RNS |
Interim Results |
25th Sep 2017 7:00 am |
RNS |
Special Shareholder Meeting & Change of Directors |